본문 바로가기
KERD
논문KCI 등재

급성 세균성 전립선염에 대한 최신 지견

Update of Acute Bacterial Prostatitis

최우석|손환철
대한요로생식기감염학회|2011.04|Urogenital Tract Infection|제6권 제1호|pp. 8-17

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

Urinary tract infectionsProstatitis
주제분류비뇨기과학

초록

Acute bacterial prostatitis is defined as acute infection of prostate. It is classified into category I according to the National Institutes of Health (NIH) consensus classification. Patients with acute bacterial prostatitis present with acute symptoms of urinary tract infection, including urinary frequency, dysuria and symptoms suggestive of systemic infection, such as malaise, fever and myalgia. The prostate may be swollen and tender on digital rectal examination, butprostatic massage is contraindicated. The most common pathogen is Escherichia coli. For initial therapy, high doses of bactericidal antibiotics, such as abroad-spectrum penicillin, a third-generation cephalosporin or a fluoroquinolone may be administered parentally and these regimens may be combined with an aminoglycoside. After defeverescence and normalization of infection parameters, oral antibiotic therapy can be continued for 2 to 4weeks. We should bear in mind that acute bacterial prostatitis secondary to manipulation of the lower urinary tract, such as transrectal prostatic needle biopsy,has more aggressive clinical course.

Abstract

Acute bacterial prostatitis is defined as acute infection of prostate. It is classified into category I according to the National Institutes of Health (NIH) consensus classification. Patients with acute bacterial prostatitis present with acute symptoms of urinary tract infection, including urinary frequency, dysuria and symptoms suggestive of systemic infection, such as malaise, fever and myalgia. The prostate may be swollen and tender on digital rectal examination, butprostatic massage is contraindicated. The most common pathogen is Escherichia coli. For initial therapy, high doses of bactericidal antibiotics, such as abroad-spectrum penicillin, a third-generation cephalosporin or a fluoroquinolone may be administered parentally and these regimens may be combined with an aminoglycoside. After defeverescence and normalization of infection parameters, oral antibiotic therapy can be continued for 2 to 4weeks. We should bear in mind that acute bacterial prostatitis secondary to manipulation of the lower urinary tract, such as transrectal prostatic needle biopsy,has more aggressive clinical course.

참고문헌 (57)

  1. Vahlensieck W Jr, "Acute prostatitis and prostatic abscess, in the Prostatitis. 1st ed", pp.133~148 (1994), Springer-Verlag
  2. Neal DE Jr, "Acute bacterial prostatitis, in the Textbook of prostatitis. 1st ed", pp.115~121 (1999), Isis Medical Media
  3. Krieger JN, "NIH consensus definition and classification of prostatitis", JAMA, 282, pp.236~237 (1999)
  4. Roberts RO, "Prevalenceof a physician- assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men", Urology, 51, pp.578~584 (1998)
  5. Wagenlehner FM, "The role of antibiotics in chronic bacterial prostatitis", Int J Antimicrob Agents, 26, pp.1~7 (2005)
  6. McRae SN, "Bacterial infections of the genitourinary tract, in the Smith's general urology. 15th ed", pp.254~260 (2000), McGraw-Hill
  7. Neal DE Jr, "Treatment of acute prostatitis, in the Textbook of prostatitis. 1st ed", pp.279~284 (1999), Isis Medical Media
  8. Nickel JC, "Prostatitis: evolving management strategies", Urol Clin North Am, 26, pp.737~751 (1999)
  9. Clemens JQ, "Prevalence of and risk factors for prostatitis: population based assessment using physician assigned diagnoses", J Urol, 178, pp.1333~1337 (2007)
  10. Nickel JC, "Prevalenceof prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index", J Urol, 165, pp.842~845 (2001)
  11. Etienne M, "Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis", BMC Infect Dis, 8, pp.12~ (2008)
  12. Millán-Rodríguez F, "Acute bacterial prostatitis: two different sub-categories according to a previous manipulation of the lower urinary tract", World J Urol, 24, pp.45~50 (2006)
  13. 김상진, "Risk Factors for Acute Prostatitis after Transrectal Biopsy of the Prostate", Korean Journal of Urology, 51(6), pp.426~430 (2010), 대한비뇨기과학회
  14. Shigehara K, "Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis", J Infect Chemother, 14, pp.40~43 (2008)
  15. Lindert KA, "Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy", J Urol, 164, pp.76~80 (2000)
  16. Lindstedt S, "Single-dose antibiotic prophylaxis in core prostate biopsy: impact of timing and identification of risk factors", Eur Urol, 50, pp.832~837 (2006)
  17. Nickel JC, "Inflammatory Conditions of the Male Genitourinary Tract: Prostatitis and Related Conditions, Orchitis, and Epididymitis, in the Campbell-Walsh urology. 9th ed", pp.304~329 (2007), Saunders
  18. Roberts RO, "A review of clinical and pathological prostatitis syndromes", Urology, 49, pp.809~821 (1997)
  19. Rothman JR, "Prostatitis: updates on diagnostic evaluation", Curr Urol Rep, 8, pp.301~306 (2007)
  20. Hara N, "Application of serum PSA to identify acute bacterial prostatitis in patients with fever of unknown origin or symptoms of acute pyelonephritis", Prostate, 60, pp.282~288 (2004)
  21. Neal DE Jr, "Prostate specific antigen and prostatitis. I. Effect of prostatitis on serum PSA in the human and nonhuman primate", Prostate, 20, pp.105~111 (1992)
  22. Schaeffer AJ, "Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen", J Urol, 174, pp.161~164 (2005)
  23. McMurray BR, "Usefulness of blood cultures in pyelonephritis", Am J Emerg Med, 15, pp.137~140 (1997)
  24. 조인래, "급성 세균성 전립선염 환자의 임상적 경과", Korean Journal of Urology, 46(10), pp.1034~1039 (2005), 대한비뇨기과학회
  25. Gamé X, "Total and free serum prostate specific antigen levels during the first month of acute prostatitis", Eur Urol, 43, pp.702~705 (2003)
  26. Yamamoto M, "Prostate-specific antigen levels in acute and chronic bacterial prostatitis", Hinyokika Kiyo, 39, pp.445~449 (1993)
  27. Irani J, "Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value", J Urol, 157, pp.1301~1303 (1997)
  28. Kravchick S, "Acute prostatitis in middle-aged men: a prospective study", BJU int, 93, pp.93~96 (2004)
  29. Sindhwani P, "Prostatitis and serum prostate- specific antigen", Curr Urol Rep, 6, pp.307~312 (2005)
  30. Horcajada JP, "Transrectal prostatic ultrasonography in acute bacterial prostatitis: findings and clinical implications", Scand J Infect Dis, 35, pp.114~120 (2003)
  31. Santillo VM, "The management of chronic prostatitis in men with HIV", Curr Urol Rep, 7, pp.313~319 (2006)
  32. Nickel JC, "Predictors of patient response to antibiotic therapy for the chronic prostatitis", chronic pelvic pain syndrome: a prospective multicenter clinical trial, 2001, pp.165, 1539~1544
  33. Danielsson D, "Demonstration of neisseria gonorrhoeae in prostatic fluid after treatment of uncomplicated gonorrhoeal urethritis", Acta Derm Venereol, 51, pp.73~76 (1971)
  34. Benway BM, "Bacterial prostatitis", Urol Clin North Am, 35, pp.23~32 (2008)
  35. Johnson JR, "Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis", J Infect Dis, 191, pp.46~50 (2005)
  36. Kanamaru S, "Increased biofilm formation in Escherichia coli isolated from acute prostatitis", Int J Antimicrob Agents, 28(1), pp.21~25 (2006)
  37. Soto SM, "Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance", J Urol, 177, pp.365~368 (2007)
  38. Costerton JW, "Bacterial biofilms in nature and disease", Annu Rev Microbiol, 41, pp.435~464 (1987)
  39. Costerton JW, "Microbial biofilms", Annu Rev Microbiol, 49, pp.711~745 (1995)
  40. "Guidelines on uological infections. European Association of Urology 2010"[URL]
  41. Bjerklund Johansen TE, "The role of antibiotics in the treatment of chronic prostatitis: a consensus statement", Eur Urol, 34, pp.457~466 (1998)
  42. Schaeffer AJ, "Prostatitis: US perspective", Int J Antimicrob Agents, 11, pp.205~211 (1999)
  43. Schaeffer AJ, "NIDDK-sponsored chronic prostatitis collaborative research network (CPCRN) 5-year data and treatment guidelines for bacterial prostatitis", Int JAntimicrob Agents, 24(1), pp.49~52 (2004)
  44. Nickel JC, "Antibiotic pharmacokinetics in the inflamed prostate", J Urol, 153, pp.527~529 (1995)
  45. Naber KG, "Antibiotic therapy-rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue", Andrologia, 35, pp.331~335 (2003)
  46. Nicolle LE, "Urinary tract infection: traditional pharmacologic therapies", Am J Med, 113(1), pp.35~44 (2002)
  47. Lee SJ, "Current status of antimicrobial resistance among bacterial pathogens causing urinary tract infection in Korea", Korean J UTII, 4, pp.37~46 (2009)
  48. Cheah PY, "Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis", chronic pelvic pain syndrome, 2004, pp.64, 881~886
  49. Doble A, "An evidence-based approach to the treatment of prostatitis: is it possible?", Curr Urol Rep, 1, pp.142~147 (2000)
  50. Carey JM, "Transrectal ultrasound guided biopsy of the prostate, in the Do enemas decrease clinically significant complications?", J Urol, 166, pp.82~85 (2001)
  51. Davidson AJ, "Multi-resistant Escherichia coli sepsis following transrectal ultrasound-guided prostate biopsy", Br J Hosp Med (Lond), 67, pp.98~99 (2006)
  52. Shah J, "Prostate abscess presenting as priapism", Int J Clin Pract Suppl, 147, pp.118~120 (2005)
  53. Chou YH, "Prostatic abscess: transrectal color Doppler ultrasonic diagnosis and minimally invasive therapeutic management", Ultrasound Med Biol, 30, pp.719~724 (2004)
  54. Göğüş C, "The value of transrectal ultrasound guided needle aspiration in treatment of prostatic abscess", Eur J Radiol, 52, pp.94~98 (2004)
  55. Ludwig M, "Diagnosis and therapeutic management of 18 patients with prostatic abscess", Urology, 53, pp.340~345 (1999)
  56. Varkarakis J, "Three-dimensional ultrasound guidance for percutaneous drainage of prostatic abscesses", Urology, 63, pp.1017~1020 (2004)
  57. Leport C, "Bacterial prostatitis in patients infected with the human immunodeficiency virus", J Urol, 141, pp.334~336 (1989)

관련 논문AI추천

급성 세균성 전립선염조용현, 하유신대한요로생식기감염학회 · Urogenital Tract Infection2011 · 제6권 제2호급성세균성전립선염의 임상적 특징 및 치료 결과배웅진, 이승주, 조수연, 조용현대한감염학회 · Infection and Chemotherapy2009 · 제41권 제1호한국인의 급성 세균성 전립선염의 특성박승철대한요로생식기감염학회 · Urogenital Tract Infection2013 · 제8권 제1호급성 세균성 전립선염의 임상경과에 관한 다기관 연구구진모, 김준모, 김철성, 김태형, 나용길, 민권식, 서영진, 심봉석, 양상국, 이길호, 이상돈, 이선주, 이성주, 이성호, 정승일, 정재민, 정희종, 조용현, 조원열, 최종보, 한창희대한요로생식기감염학회 · Urogenital Tract Infection2011 · 제6권 제2호급성전립선염 환자에서 이전 술기 유무에 따른 임상적 고찰강택원, 권동득, 김광호, 김선옥, 박광성, 정승일, 황의창대한요로생식기감염학회 · Urogenital Tract Infection2012 · 제7권 제2호급성 전립샘염에서 전립샘 농양 유무에 따른 임상경과김민의, 김영호, 김웅빈, 김준모, 이광우대한요로생식기감염학회 · Urogenital Tract Infection2011 · 제6권 제2호

이 간행물의 다른 논문 (13건)

요로생식기계 보형물삽입술의 예방적 항균제요법김태형, 김정훈pp. 1-7방광요관역류에서 예방적 항생제요법의 최신 지견김준모pp. 18-24비임균성 요도염의 최신지견김기호, 서영진pp. 25-31Extended-spectrum β-lactamases (ESBL) 성질을 가진 세균에 의한 요로감염이길호pp. 32-41염증성 만성골반통증후군과 비염증성 만성골반통증후군간의 만성전립선염 증상 점수표에 따른 임상 양상의 비교조승훈, 최재영, 김성빈, 민승기, 이명진, 이승태pp. 42-47
원문 보기